Insider trades
Joseph P. Lyssikatos, Chief Officer of Enliven Therapeutics ELVN, has filed 0 purchases and 60 sales on the open market. Over the past 12 months that comes to a net sale of $4.8M. The latest trade was on 02/12.
Joseph P. Lyssikatos
Chief Scientific Officer
- Company
- Enliven Therapeutics ELVN
- First filing
- 23/02/27
- Trades
- 94 trades
- Buys / sales
- 0 / 60
- 12-month net buying
- −$4.8M
- Last trade
- 02/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 02/06 | 02/10 | 5,000 sh | $29.04 | $145,200 | −0.7% | |
ELVN | Open-market sale10b5-1 plan | 01/20 | 01/22 | 20,000 sh2 trades | $26.75avg. | $535,089.77 | −2.6% |
ELVN | Open-market sale10b5-1 plan | 01/08–01/09 | 01/12 | 132,500 sh4 trades | $26.23avg. | $3,475,651.04 | −14.8% |
| Open-market sale10b5-1 plan | 25/12/19 | 25/12/23 | 5,000 sh | $16.84 | $84,200 | −0.6% | |
ELVN | Open-market sale10b5-1 plan | 25/11/19 | 25/11/21 | 12,500 sh2 trades | $22.33avg. | $279,138.68 | −1.4% |
| Open-market sale10b5-1 plan | 25/10/20 | 25/10/22 | 12,500 sh | $22.08 | $276,000 | −1.3% | |
| Open-market sale10b5-1 plan | 25/09/26 | 25/09/30 | 4,000 sh | $20.25 | $81,000 | −0.4% | |
| Open-market sale10b5-1 plan | 25/09/23 | 25/09/25 | 1,500 sh | $20.03 | $30,045 | −0.2% | |
ELVN | Open-market sale10b5-1 plan | 25/09/19 | 25/09/23 | 7,000 sh2 trades | $19.39avg. | $135,708.3 | −0.7% |
ELVN | Open-market sale10b5-1 plan | 25/08/19–25/08/21 | 25/08/21 | 12,500 sh2 trades | $19.85avg. | $248,175 | −1.3% |
ELVN | Open-market sale10b5-1 plan | 25/07/21 | 25/07/23 | 12,500 sh2 trades | $22.29avg. | $278,618.64 | −1.3% |
| Open-market sale10b5-1 plan | 25/06/20 | 25/06/24 | 12,500 sh | $21.40 | $267,500 | −1.3% | |
| Open-market sale10b5-1 plan | 25/06/03 | 25/06/05 | 7,500 sh | $20.03 | $150,225 | −0.8% | |
| Open-market sale10b5-1 plan | 25/05/19 | 25/05/21 | 5,000 sh | $16.31 | $81,550 | −0.5% | |
ELVN | Open-market sale10b5-1 plan | 25/05/01–25/05/02 | 25/05/05 | 7,500 sh2 trades | $20.05avg. | $150,376.8 | −0.8% |
ELVN | Open-market sale10b5-1 plan | 25/04/21 | 25/04/23 | 5,000 sh2 trades | $16.08avg. | $80,377.7 | −0.5% |
| Open-market sale10b5-1 plan | 25/03/19 | 25/03/21 | 12,500 sh | $20.61 | $257,625 | −1.2% | |
| Open-market sale10b5-1 plan | 24/10/18 | 24/10/22 | 847 sh | $30.00 | $25,410 | −0.1% | |
ELVN | Open-market sale10b5-1 plan | 24/10/08–24/10/09 | 24/10/10 | 51,145 sh4 trades | $28.11avg. | $1,437,565.28 | −4.8% |
ELVN | Open-market sale10b5-1 plan | 24/10/04–24/10/07 | 24/10/08 | 10,229 sh2 trades | $27.54avg. | $281,670.49 | −0.9% |